Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/6695Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Sinha, Nanda D | - |
| dc.contributor.author | Kuchimanchi, Satya N | - |
| dc.contributor.author | Miranda, Greg | - |
| dc.contributor.author | Shaikh, Saied | - |
| dc.date.accessioned | 2009-11-19T10:08:34Z | - |
| dc.date.available | 2009-11-19T10:08:34Z | - |
| dc.date.issued | 2006-10 | - |
| dc.identifier.issn | 0975-0983(Online); 0376-4699(Print) | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/6695 | - |
| dc.description | 2297-2304 | en_US |
| dc.description.abstract | The optimization of synthesis, purification process parameters and development of new reagents have enabled successful large-scale manufacture of several therapeutic grade oligonucleotides at Avecia. The development of new reagents and processes are described in this communication. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | CSIR | en_US |
| dc.relation.ispartofseries | Int.Cl.8C07D | en_US |
| dc.source | IJC-B Vol.45B(10) [October 2006] | en_US |
| dc.subject | Oligonucleotides | en_US |
| dc.subject | manufacture | en_US |
| dc.subject | antisense | en_US |
| dc.subject | RNAi (RNA interfererence) | en_US |
| dc.subject | aptamer | en_US |
| dc.subject | green chemistry | en_US |
| dc.title | Manufacture of therapeutic oligonucleotides: Development of new reagents and processes | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | IJC-B Vol.45B(10) [October 2006] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJCB 45B(10) 2297-2304.pdf | 123.84 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.